Hemodynamic Monitoring in Liver Transplant With VEnaRt Cardiac Output Versus Swan-Ganz Catheter (VERO Study)

Azienda Sanitaria-Universitaria Integrata di Udine

Status: Completed

Conditions: Liver Transplant; Complications; Cardiac Output, Low

Treatments: Device: VEnaRt Cardiac Output

Study type: Observational

Funder types: Other

Identifiers

NCT04825015

CEUR-2020-OS-299

Details and patient eligibility

About

The Swan-Ganz catheter is the gold standard to measure cardiac output during liver transplantation surgery. This is an invasive hemodynamic monitoring system.

The VenArt Cardiac Output (Mespere LifeSciences, Waterloo, Canada) is a new, innovative and non-invasive device that permits hemodynamic monitoring.

With a software based on Fick's principle it is able to calculate cardiac output, cardiac index and continuous cardiac output.

The hypothesis of this study is to investigate the precision and accuracy of this method versus the standard of care during liver transplantation.

Enrollment: 26 patients

Sex: All

Ages: 18 to 99 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• liver transplantation patients

Exclusion criteria

• age < 18 years old
• combined liver-kidney transplant
• liver transplant for acute insufficiency
• no consent of the patient

Trial design

26 participants in 1 patient group

OLTx

Description:

Liver insufficiency patients undergoing transplantation surgery

Treatment:

Device: VEnaRt Cardiac Output